Tourmaline Bio
Sandeep Kulkarni is a highly accomplished professional with a background in medicine and economics. Sandeep has held various leadership positions in the biotech and investment industries, including Chief Executive Officer at Tourmaline Bio and Managing Director at KVP Capital. With a MD from the University of California, San Francisco and a AB in Economics from Harvard University, Sandeep brings a unique blend of expertise to their current role as a Board Member at Zura Bio Limited.
Tourmaline Bio
2 followers
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.